Baseline characteristics

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] · Source last updated 2026-07-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      1280

   units

   Participants

groups

1. description

   All participants received up to four 21-day cycles of cisplatin-based chemotherapy (cisplatin plus either vinorelbine or docetaxel or gemcitabine or pemetrexed \[non-squamous cell NSCLC only\] based on investigator's choice), unless unacceptable toxicity, disease relapse, or participant's decision to discontinue occurred.

   id

   BG000

   title

   Enrollment Phase

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            8.7

            value

            61.4

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            427

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            853

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            18

         title

         Hispanic or Latino

      2. measurements

         1. group Id

            BG000

            value

            1219

         title

         Not Hispanic or Latino

      3. measurements

         1. group Id

            BG000

            value

            43

         title

         Unknown or Not Reported

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Ethnicity (NIH/OMB)

   unit Of Measure

   Participants

4. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         title

         American Indian or Alaska Native

      2. measurements

         1. group Id

            BG000

            value

            307

         title

         Asian

      3. measurements

         1. group Id

            BG000

            value

            2

         title

         Native Hawaiian or Other Pacific Islander

      4. measurements

         1. group Id

            BG000

            value

            8

         title

         Black or African American

      5. measurements

         1. group Id

            BG000

            value

            935

         title

         White

      6. measurements

         1. group Id

            BG000

            value

            1

         title

         More than one race

      7. measurements

         1. group Id

            BG000

            value

            27

         title

         Unknown or Not Reported

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race (NIH/OMB)

   unit Of Measure

   Participants

population Description

Enrolled population was defined as all eligible participants who were enrolled in the enrollment phase, regardless if they are subsequently randomized or not.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice